Nasdaq:US$15.69 (+0.28) | HKEX:HK$25.40 (+0.50) | AIM:£2.21 (-0.02)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 16 Apr 2023

AACR 2023: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2